(Q46569225)

23 December 2017

title

Absence of Kaposi sarcoma among Ethiopian immigrants to Israel despite high seroprevalence of human herpesvirus 8. (English)

1 reference

23 December 2017

Kaposi's sarcoma-associated herpesvirus

0 references

0 references

0 references

0 references

object named as

human herpesvirus 8

1 reference

Zehava Grossman

1

1 reference

23 December 2017

Jose Iscovich

2

1 reference

23 December 2017

Fidi Schwartz

3

1 reference

23 December 2017

Esther Azizi

4

1 reference

23 December 2017

Avraham Klepfish

5

1 reference

23 December 2017

Ami Schattner

6

1 reference

23 December 2017

Ronit Sarid

7

1 reference

23 December 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

23 December 2017

published in

Mayo Clin Proc

1 reference

23 December 2017

volume

77

1 reference

23 December 2017

issue

9

1 reference

23 December 2017

page(s)

905-909

1 reference

23 December 2017

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Classic Kaposi's sarcoma in Jews living in Israel, 1961-1989: a population-based incidence study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Comparison of the distribution of non-AIDS Kaposi's sarcoma and non-Hodgkin's lymphoma in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Sexual transmission and the natural history of human herpesvirus 8 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Prevalence of human herpesvirus 8 infection before the acquired immunodeficiency disease syndrome-related epidemic of Kaposi's sarcoma in East Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Dermatology in southwestern Ethiopia: rationale for a community approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Evaluation of the World Health Organization staging system for HIV infection and disease in Ethiopia: association between clinical stages and laboratory markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2811%2962256-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0025-6196(11)62256-8

1 reference

23 December 2017

PubMed ID

12233922

1 reference

23 December 2017